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Nonhuman primate neuroimaging is on the cusp of a transformation, much in the same way its human coun-
terpart was in 2010, when the Human Connectome Project was launched to accelerate progress. Inspired by
an open data-sharing initiative, the global community recently met and, in this article, breaks through
obstacles to define its ambitions.Nonhuman primate (NHP) neuroimaging
carries tremendous translational promise
for biomedicine (Phillips et al., 2014;
Roelfsema and Treue, 2014). However,
progress has been slow, as researchers
face not only the many challenges that
human neuroimaging has overcome but
also unique obstacles that require
consensus solutions. To date, the
approach has remained largely piecemeal
and single-lab driven, causing most
NHP researchers to struggle to amass
datasets consisting of even 10 to 20 sub-
jects, whereas their human-imaging
counterparts now aim for thousands.
The PRIMatE Data Exchange (PRIME-
DE) was recently established to accel-
erate the pace of advancement (Milham
et al., 2018) by promoting a culture of
collaboration and open science in the
NHP neuroimaging community. PRIME-
DE established a repository of openly
shared data in 2018, followed by a Global
Collaboration Workshop (GCW) on
September 5–6, 2019 at the Wellcome
Trust in London. Through these efforts,
the community has made substantial
progress toward a global vision and here
outlines its ambitious albeit eminently
achievable goals. Four key domains of
activity in NHP neuroimaging are consid-
ered that can dramatically accelerate
progress.
Standardizing Data Collection
Harmonizing Data Collection Is Key
for Reproducibility and Shared
Data Value
Minimal Data Acquisition Specifications.
There was agreement that a universal
data acquisition protocol is not yet prac-
tical, but minimal specifications can be
defined toward standardization. A shared600 Neuron 105, February 19, 2020 ª 2019 Elesson from the Human Connectome
Project (Van Essen et al., 2013) is that
the cortical sheet should be resolvable
with isotropic voxels no larger than half
the minimum cortical thickness (e.g.,
0.5–0.6 mm voxels for macaque cortex
and 0.4 mm for marmosets). Acquiring
3D T1- and T2-weighted scans is impor-
tant for brain segmentation, and T1/T2
ratios can generate ‘‘myelin maps’’ to
assist surface mapping and rapid quality
checking.
For functional MRI, attainable target
spatial resolutions are 1.0-mm isotropic
voxels for large NHPs and 0.5 mm for
smaller ones. However, these are beyond
the 1.2–1.5 mm range currently employed
on common 3 Tesla scanners, and
manufacturers are phasing out gradient
inserts previously used to boost signal-
to-noise. A way forward is the adoption
of more sophisticated coil systems with
higher signal to noise (SNR), enhanced
with acceleration methods (multiband im-
aging) for higher functional and temporal
resolution with less acquisition time.
These coils are commercially available
(24-channel macaque, 16-channel
marmoset) though still require customiza-
tion to accommodate head posts and/or
chambers.
Anesthetized Imaging. Although
awake imaging is clearly the long-term
aspiration for NHP imaging, it is techni-
cally challenging and requires training
the subject. Thus, anesthetized imaging
remains important for resting-state,
diffusion, and structural imaging and
benefits from minimal head motion. A
key factor for establishing common
practice is standardizing the anesthetic
agents. Many GCW laboratories
already use highly similar protocols,lsevier Inc.entailing isoflurane anesthesia for
structural imaging and IV administration
of dexmedetomidine (0.015–0.02mg per
kg bolus or 4.5–5.0ug per kg per h infu-
sion) to allow reduction of isoflurane
concentrations to between 0.6%–1.0%
to improve the functional MRI signal.
Other agents are being successfully
employed and might be required by
researchers for scientific reasons (Fleck-
nell, 2015). Beyond the specific agents
employed, opportunities exist to
advance the monitoring and control of
anesthesia depth throughout scanning
by logging temperature, end tidal CO2,
O2 saturation, respiration rate, heart
rate, and blood pressure synchronized
to data acquisition.
Awake Imaging. Four identifiable chal-
lenges confront awake NHP imaging.
First is the challenge of behavioral
training for the scanner environment.
Second, the placement of head immobi-
lization hardware determines which
brain areas are accessible with head
coils. This precludes universal accep-
tance of a single head coil and necessi-
tates customization or generating a
range of standardized options. Third,
noninvasive eye tracking provides a
key control measure in awake NHPs.
Finally, head and jaw movements, as
well as the apparent head movement
and brain distortions produced by
changes in susceptibility from body
and limb motion, remain a problem for
awake imaging, particularly at high
magnetic fields. Behavioral training and
external monitoring methods, such as
magnetic resonance (MR)-compatible
video tracking and jaw and/or body
motion sensors, can be invaluable
for correcting motion. Post-acquisition
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will help; and film viewing, when appro-
priate, can decrease head motion (as re-
ported in human neuroimaging).
Opportunities for Improving Data
Quality. Although using higher field
scanners is an obvious way to improve
data quality, current costs (1 million
USD per Tesla) and operational nuances
make them relatively inaccessible to
most groups. Recent findings suggest
that iron-based contrast agents such
as monocrystalline iron oxide nanopar-
ticle (MION) can increase contrast-to-
noise ratio (CNR) and spatial specificity
at 3 T. However, this has limitations, as
the agents tend to be costly, and
frequent usage necessitates the intro-
duction of chelating agents to minimize
impact on animal welfare by long-term
accumulation of iron. Additionally,
contrast agents measure cerebral blood
volume (CBV) rather than the blood-
oxygenation-level-dependent (BOLD)
response, complicating comparison to
human BOLD fMRI. Unlike human MRI,
NHP MRI suffers from dramatic signal
variations from coils or other sources.
Thus, appropriate quality control strate-
gies should be implemented both for
custom and standard coils. An approach
to improve fMRI data quality is to in-
crease the number and duration of
acquisition sessions (Xu et al., 2018).
Prospective motion correction ap-
proaches deployed in human research
(Maclaren et al., 2013) may also improve
structural imaging. Currently, the main
way to avoid motion artifacts in awake
imaging is to limit head movements
(e.g., training or head immobilizing).
Finally, investigators identified the
need for creating and sharing NHP
‘‘phantoms,’’ which would allow data-
collection sites to check and benchmark
their data-collection protocols using
a common reference as is done in hu-
man imaging. Such phantoms would
be created and made freely available
as a 3D-printed model of a given spe-
cies’ brain filled with a contrast agent
with known relaxation times to stan-
dardize signal-to-noise assessment
across sites. Phantoms could be
created for any of the primate species
(apes, marmosets, baboons, ma-
caques). Importantly, working on good
quality data acquisition beats anypost-acquisition cleaning algorithm
available and is crucial if we are to
create standard pipelines for NHP MRI
data analysis.
Animal Welfare, Regulations, and
Intellectual Property
NHP Imaging Stakeholders Are
Seeking Policy-Making Guidance
from and Working with Funding
Agencies, Professional Societies,
and the Larger Community to
Ensure Maximum Benefit and
Transparency
Animal Welfare and Regulations. NHP
neuroscience is a heavily scrutinized and
extremely sensitive area of research with
extensive ethical approval processes
and oversight. However, NHP research
is not governed by a common set of inter-
national regulations or ethical statements
(e.g., Declaration of Helsinki for human
research). National differences in NHP
research and NHP welfare regulations
are particularly problematic for efforts to
collaborate internationally. The commu-
nity agreed that addressing this challenge
going forward will benefit from additional
transparency when sharing their datasets,
including identification of the relevant
regulatory body and reference to their
published standards. Additionally, it will
be important to increase the collection
and sharing alongside MRI data of objec-
tive and evidence-based measures of an-
imal health status as metadata, which can
also provide scientific insights (e.g.,
home-cage behavioral data, eye-tracking
data, genomic information, rearing and
maintenance information, sourcing of
animals, anesthesia maintenance values,
as relevant). National primate centers
and breeding sites can help with collec-
tion of this metadata.
Engaging the Public. Candid and trans-
parent communication with the public on
the importance of nonhuman animal
research is vital for maintaining and
increasing governmental and public sup-
port. It is not uncommon for institutions
and scientists to find themselves in a
reactive rather than proactive position,
focusing solely on the defense of their
work. Recent experience is showing that
a proactive stance raises public aware-
ness and support for animal research as
a key element of modern science and
medicine, balancing the discussion ofconcerns raised by activist groups. Politi-
cians are often unaware of the impact of
the animal research occurring in their
own constituencies, which can lead to
legislation being put forward that fails to
capture the importance of scientific ad-
vances. Institutional and funding-body
press offices could better link transla-
tional developments directly to the foun-
dational research performed on labora-
tory animals because the reporting of the
fundamental animal research bases is
often unmentioned. Researchers and
their institutions can find support and
public-engagement training from groups
such as Speaking of Research (US),
Basel Declaration on Animal Research
(EU), Pro-Test Deutschland (GER), Pro-
Test Italia (ITL), Understanding Animal
Research (UK), and Gircor (FRA).
Alongside the importance of the work,
the public can learn about the balance
between benefits and harms, including
evidence-based safeguards for animal
welfare. Several institutions have
now signed the UK Concordat on
Openness in Animal Research (http://
concordatopenness.org.uk). This now
five-year-old agreement, currently signed
by 122 institutions, encourages openness
and better information sharing about
animal research. Rather than being a
generic statement on openness that will
find nominal support by most institutions,
the Concordat annually assesses, sup-
ports, and rewards institutional public
engagement efforts. Communication ef-
forts emerging from signatories of this
agreement have been impressive (more
useful information on institutional web-
sites, patient-led activities, virtual tours
of animal facilities, and better-balanced
social media discussions). Lastly, the
community noted the need for increased
leadership from the national and interna-
tional research organizations in efforts to
explain the continued importance of
NHP research, supporting researchers
and engaging the public.
Crediting and Intellectual Property. In
NHP research, where substantial costs
and efforts are required for training or
maintenance of a single individual, investi-
gators hold real concerns about not being
appropriately credited or being ‘‘scooped’’
analytically with one’s own data. Recent
years have witnessed an increasing
acceptance of ‘‘data descriptors’’ orNeuron 105, February 19, 2020 601
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structures (Neuroimaging Informatics
Tools and Resources Clearinghouse
[NITRC], Zenodo) as a publication-based
means of crediting data generators and
encouraging sharing. Digital object identi-
fiers (DOI) assigned to datasets can further
assure the rapid identification, crediting,
and tracking of datasets. However, such
efforts need to be recognized by the insti-
tutions and used in promotion reviews
(e.g., Declaration on Research Assess-
ment, https://sfdora.org). This situation is
problematic for the advancement of open
science andmust be addressed by a coor-
dinated effort involving both institutions
and funders recognizing the importance
of data generation and sharing. These real-
ities often drive investigators to hold back
their newest data from sharing initiatives,
instead sharing only those datasets that
have already yielded publications.
GCWparticipants converged on a solu-
tion that moving forward, in addition to
fully open sharing options, a ‘‘collabora-
tion seeking’’ sharing option will be added
with the following terms: (1) early sharing
encouraged, but an investigator can
accept or reject access requests to
these data; (2) the investigative team
may receive co-authorship credit on the
publication (to be negotiated by the
dataset holders and proposed collabo-
rator); and (3) upon publication of the
first manuscript, the data status will
switch to open sharing. Additionally,
GCW participants felt that the generation
of a registry of ongoing studies would
be immensely important for the NHP
research community to avoid duplicating
efforts and to foster collaboration.
Finally, the issue of using shared data for
commercial purposes remains unre-
solved. In human studies, the data gener-
ators can consent to commercial use or
not, but for the NHP community, it is
less clear if ownership lies with the data
generator, institution, or funder.
Data Standards, Quality
Assessment, and Analytic
Softwares
The Adoption of Data Standards and
Open Analytic Solutions Are Readily
Attainable
Data Standards. There is a clear need
for metadata standards in NHP data
acquisition. The Brain Imaging Data602 Neuron 105, February 19, 2020Structure (BIDS) framework (Gorgolewski
et al., 2016), used in the initial PRIME-
DE data release, is recommended given
its rapid maturation and widespread
adoption in human neuroimaging,
including EEG and MEG. However, the
BIDS format will require revision to cap-
ture the range of metadata unique to
NHPs. Minimally, species and scanning
position (upright, sphinx) require specifi-
cation. Metadata could also include de-
tails regarding anesthesia protocol,
contrast agents, coil type (surface versus
volume), head-fixation information, sub-
species, age, sex, universal specimen
identifiers, body weight, available
genomic information, and animal origin.
The NIfTI (Neuroimaging Informatics
Technology Initiative) and GIfTI (geometry
format under NIfTI) formats, for volumetric
and surface datasets respectively, pro-
vide a standard for porting data between
software packages. The CIFTI (Connec-
tivity Informatics Technology Initiative)
format appears to be well positioned as
a framework for connectivity analyses
that span surface-based representations
and subcortical regions.
Quality Assessment.NHP imagers have
yet to reach a consensus on quality
assessment or assurance. Some datasets
might be of higher quality, even if these
are from fewer animals. There are also
concerns that implementing high QC
standards at this initial stage will stall
data sharing, and analytic methods
may be developed to rescue lower
quality data. In the human literature,
steps toward universal approaches to
quantify data quality are being made
(e.g., MRIQC) and could be adapted for
NHP imaging. However, most existing
tools are optimized for human heads,
which have very different tissue profiles
and are imaged at lower resolution. Inves-
tigators are leveraging technical ad-
vances (e.g., multichannel segmentation,
deep learning, improved templates) to
break through this barrier and avoid
manual correction. However, at present,
visual inspection and ratings remain key
steps for quality assessment and analyt-
ical validation. Given these realities, the
PRIME-DE consortium has recommen-
ded sharing all data regardless of data
quality and to share QC ratings for the
datasets. Finally, real-time quality assess-
ments have been recently automated inthe human literature (e.g., the Framewise
Integrated Real-time MRI Monitoring
[FIRMM]) and could be adapted for NHP
imaging for motion monitoring, feedback,
and to assess when sufficient data have
been collected.
Pipelines. There is a scarcity of end-to-
end NHP image preprocessing pipeline
solutions, including surface-based ana-
lyses. Investigators identified a range of
open-source tools and pipelines that are
available or progressing in their develop-
ment, making it just a matter of time
until the reliance on in-house code de-
creases. This process can be accelerated
through establishing mechanisms for
rapid communication of developments
via wikis, mailing lists, technical notes,
code repositories, notebooking sites,
and Brainhack events. Such communica-
tion is especially important in assisting
investigators from outside of NHP imag-
ing to engage with this community’s
data. Publication of methods papers is
encouraged and their value should be
considered in assessing a researcher’s
productivity. Lastly, it is worth noting
that scientists are making progress in
tackling the challenges of within and
interspecies alignment. These efforts
are crucial not only in advancing our
understanding of the NHP brain but also
in creating a common terminology be-
tween researchers from human imaging
and the NHP community who quite
often still use different vocabularies. A
critical ongoing effort by some groups
attending the GCW is the alignment of
imaging and digitization of the wealth of
histological and tract-tracing data in
NHPs. With sufficient investment, such
important data could be curated, helping
to bridge analytical scales.
Coordinated Paradigm Design
Common Ground in Functional
Imaging Creates Opportunities for
Globally Coordinated Activity
Functional localizers are commonly used
in human and NHP imaging, spanning
retinotopy, tonotopy, object perception,
somatotopy, eye movements, social
cognition, and more. To date, labs have
tended to use customized approaches
by creating and using their own localizer
stimuli, typically in a relatively limited
number of subjects. Commonalities in
focus areas across laboratories create
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design and data sharing. First, the simple
sharing of final statistical maps (e.g., via
NeuroVault, Open Science Framework,
or the Brain Analysis Library of Spatial
Maps and Atlases [BALSA]) would gener-
ously allow applying meta-analytic tech-
niques and aggregating across site infor-
mation. Equally important, the sharing of
functional localizer stimuli would allow
harmonizing efforts and, as a result,
improve the likelihood of reproducible
findings, dramatically enhancing the value
of shared datasets. Complementing
lower-level functional localizers are natu-
ralistic stimuli (e.g., films), which can be
used to probe a range of systems,
including higher-order association areas.
Unfortunately, there is great variation in
naturalistic stimuli across laboratories
and in custom analyses that are needed
to extract meaningful information from
these localizers. As a first step, the com-
munity agreed that small groups will
work together on obtaining coordinated
localizer data for different modalities in
30 individuals as a basis for creating tem-
plate-based probabilistic maps. These
data will be invaluable to the broader
community that often requires information
on where functional fiducials reside in
specific individuals. Long term, the com-
munity wants to work toward generating
a collection of natural films and analytical
approaches for a rapid (10–15 min) multi-
faceted ‘‘primate global localizer’’ that
could be used by many laboratories. Its
usefulness will need to be validated and
established alongside information from
accepted localizers.
Ambitions for the Next Five Years
Over the course of the next five to ten
years, the PRIME-DE GCW attendees
agreed that it will be possible to collect
and share structural scans from 1,000
NHPs in various species with further
grassroots sharing efforts of higher quality
and more extensive datasets in 200 ani-
mals. With financial support, the coordi-nation of activities centered around local-
izers could yield data from 30 animals
for a given localizer, as the community
works toward a multi-faceted primate
functional localizer. More substantial in-
vestment would allow the generation of
a large-scale, multimodal resource for
NHPs similar to the Human Connectome
Project, possibly including developmental
samples (pediatric, fetal) and metadata
(genotyping and phenotyping information,
etc.). The integration of digitized neuronal
tract tracing data, neurophysiology (high
density recordings, laminar, etc.), histol-
ogy, and neuromodulation approaches
(optogenetics, electrical microstimula-
tion, pharmacological inactivation, ultra-
sound, etc.) would bring unprecedented
value to the resource.Conclusion
We have synthesized a perspective put
forward by the GCWmeeting on the chal-
lenges and opportunities for NHP imaging
and the ambitions of the community.
Given the grassroots nature of the effort,
the community recognized the need to
meet regularly to strengthen communica-
tion and facilitate progress. Following the
lead of its human counterpart, NHP imag-
ing is unquestionably evolving toward
reproducible and scalable science. To
accelerate the pace of its evolution
through increased collaboration, sharing,
and investment, large-scale global neuro-
science ventures (e.g., the BRAIN Initia-
tive, Human Brain Project) and other fund-
ing schemes will need to support the
community objectives for the next five to
ten years of data generation and sharing.
If the PRIME-DE GCW serves as a litmus
test, exciting advances, and discoveries
will become evident by global collabora-
tion and support.SUPPLEMENTAL INFORMATION
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